Our results identified that TMED5 was directly targeted and inhibited by miR-183-5p, and TMED5 knockdown phenocopied miR-183-5p overexpression in suppressing cervical cancer development and angiogenesis. This evidence concerns the gene TMED5 and cervical cancer.